Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-26 @ 3:15 AM
Study NCT ID:
NCT01226420
Status:
TERMINATED
Last Update Posted:
2013-08-13
First Post:
2010-10-21
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2012-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-21
First Submit QC Date:
None
Study First Post Date:
2010-10-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-28
Results First Submit QC Date:
None
Results First Post Date:
2013-08-13
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-08-11
Last Update Post Date:
2013-08-13
Last Update Post Date Type:
ESTIMATED